Robuta

https://www.technologynetworks.com/genomics/news/stratagene-expands-rights-to-molecular-diagnostics-intellectual-property-portfolio-210410
Stratagene acquires exclusive licensing option to family of gene expression predictors for bladder cancer.
molecular diagnosticsintellectual propertystratageneexpandsrights